Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Absence of mutations on the SNF5 gene in hematological neoplasms with chromosome 22 abnormalities.

Mori N, Inoue K, Okada M, Motoji T.

Acta Haematol. 2011;126(2):69-75. doi: 10.1159/000324932. Epub 2011 Apr 13.

PMID:
21494030
2.
3.

High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.

Hasselblatt M, Isken S, Linge A, Eikmeier K, Jeibmann A, Oyen F, Nagel I, Richter J, Bartelheim K, Kordes U, Schneppenheim R, Frühwald M, Siebert R, Paulus W.

Genes Chromosomes Cancer. 2013 Feb;52(2):185-90. doi: 10.1002/gcc.22018. Epub 2012 Oct 17.

PMID:
23074045
4.

Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.

Yamamoto H, Kohashi K, Tsuneyoshi M, Oda Y.

Pathobiology. 2011;78(3):132-9. doi: 10.1159/000323564. Epub 2011 May 26.

PMID:
21613800
5.

Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.

Kraus JA, de Millas W, Sörensen N, Herbold C, Schichor C, Tonn JC, Wiestler OD, von Deimling A, Pietsch T.

Acta Neuropathol. 2001 Jul;102(1):69-74.

PMID:
11547953
6.

Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.

Fujisawa H, Misaki K, Takabatake Y, Hasegawa M, Yamashita J.

J Neurooncol. 2005 Jun;73(2):117-24.

PMID:
15981100
7.

A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications.

Wild A, Langer P, Ramaswamy A, Chaloupka B, Bartsch DK.

J Clin Endocrinol Metab. 2001 Dec;86(12):5782-7.

PMID:
11739439
8.
9.

SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.

Bahrami A, Lee S, Caradine KD, Raimondi SC, Folpe AL.

Cancer Genet. 2014 Sep;207(9):437-40. doi: 10.1016/j.cancergen.2014.08.002. Epub 2014 Aug 24.

PMID:
25312828
10.
11.

Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.

Grand F, Kulkarni S, Chase A, Goldman JM, Gordon M, Cross NC.

Cancer Res. 1999 Aug 15;59(16):3870-4.

12.

Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.

Jackson EM, Sievert AJ, Gai X, Hakonarson H, Judkins AR, Tooke L, Perin JC, Xie H, Shaikh TH, Biegel JA.

Clin Cancer Res. 2009 Mar 15;15(6):1923-30. doi: 10.1158/1078-0432.CCR-08-2091. Epub 2009 Mar 10.

13.

Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.

Svobodova K, Zemanova Z, Lhotska H, Novakova M, Podskalska L, Belickova M, Brezinova J, Sarova I, Izakova S, Lizcova L, Berkova A, Siskova M, Jonasova A, Cermak J, Michalova K.

Leuk Res. 2016 Mar;42:7-12. doi: 10.1016/j.leukres.2016.01.009. Epub 2016 Jan 24.

PMID:
26851439
14.
15.

High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.

Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, Nikkel SM, Zuppan CW, Wainwright LM, Zhang F, Biegel JA.

Hum Genet. 2007 Sep;122(2):117-27. Epub 2007 May 31.

PMID:
17541642
16.

INI1 mutations in meningiomas at a potential hotspot in exon 9.

Schmitz U, Mueller W, Weber M, Sévenet N, Delattre O, von Deimling A.

Br J Cancer. 2001 Jan;84(2):199-201.

17.
18.

Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.

Liu D, Zhang Y, Chen S, Pan J, He X, Liang J, Chen Z.

Cancer Genet. 2015 Jun;208(6):333-40. doi: 10.1016/j.cancergen.2015.03.013. Epub 2015 Apr 9.

PMID:
26032184
19.

Interstitial deletion of the short arm of chromosome 12 during clonal evolution in myelodysplastic syndrome with t(5;12)(q13;p13) involving the ETV6 gene.

Yamamoto K, Nagata K, Yagasaki F, Tsurukubo Y, Tamura A, Taniwaki M, Hamaguchi H.

Cancer Genet Cytogenet. 2000 Jun;119(2):113-7. Review.

PMID:
10867145
20.

Mutational analysis of INI1 in sporadic human brain tumors.

Weber M, Stockhammer F, Schmitz U, von Deimling A.

Acta Neuropathol. 2001 May;101(5):479-82.

PMID:
11484819

Supplemental Content

Support Center